Why the study?
Understanding metabolic interactions between immune cells and cardiomyocytes during heart failure progression is essential to developing targeted therapies that regulate immunometabolism in the heart.
This review highlights the critical metabolic interactions between immune cells and cardiomyocytes during heart failure progression, suggesting potential targets for immunometabolic therapies.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Erebholo et al. (2026) conducted a review in Heart failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: